ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma
Abstract Ovarian carcinoma (OC) is the most lethal gynecological malignancy due to frequent recurrence resulting from cisplatin-resistance. ARL6IP5 is a novel gene implicated to suppress cisplatin-resistance by activating apoptosis and inhibiting DNA repair through XRCC1 and PARP1. We investigated t...
Main Authors: | Ji-Ye Kim, Entaz Bahar, Jung-Yun Lee, Sunhee Chang, Se Hoon Kim, Eun Young Park, Sung-Im Do, Hyonok Yoon, Hyun-Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-03-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-04568-4 |
Similar Items
-
Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway
by: Entaz Bahar, et al.
Published: (2021-04-01) -
Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression
by: Entaz Bahar, et al.
Published: (2020-10-01) -
Modeling and Predicting the Cell Migration Properties from Scratch Wound Healing Assay on Cisplatin-Resistant Ovarian Cancer Cell Lines Using Artificial Neural Network
by: Entaz Bahar, et al.
Published: (2021-07-01) -
Lidocaine: A Local Anesthetic, Its Adverse Effects and Management
by: Entaz Bahar, et al.
Published: (2021-07-01) -
Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling
by: Entaz Bahar, et al.
Published: (2019-03-01)